Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4554667
Max Phase: Preclinical
Molecular Formula: C42H45N9O6
Molecular Weight: 771.88
Molecule Type: Unknown
Associated Items:
ID: ALA4554667
Max Phase: Preclinical
Molecular Formula: C42H45N9O6
Molecular Weight: 771.88
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ccc(-n2cc(CN(NC(=O)Cc3ccccc3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](Cc3cccnc3)C(=O)N[C@H](CC(=O)O)Cc3ccccc3)nn2)cc1
Standard InChI: InChI=1S/C42H45N9O6/c1-29-16-18-35(19-17-29)50-27-34(46-48-50)28-51(47-38(52)24-31-12-6-3-7-13-31)42(57)49-21-9-15-37(49)41(56)45-36(23-32-14-8-20-43-26-32)40(55)44-33(25-39(53)54)22-30-10-4-2-5-11-30/h2-8,10-14,16-20,26-27,33,36-37H,9,15,21-25,28H2,1H3,(H,44,55)(H,45,56)(H,47,52)(H,53,54)/t33-,36-,37-/m0/s1
Standard InChI Key: YYTZAEPEQCIRLF-WOFUPGFCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 771.88 | Molecular Weight (Monoisotopic): 771.3493 | AlogP: 3.56 | #Rotatable Bonds: 15 |
Polar Surface Area: 191.75 | Molecular Species: ACID | HBA: 9 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 15 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 4.07 | CX Basic pKa: 4.98 | CX LogP: 2.90 | CX LogD: 0.76 |
Aromatic Rings: 5 | Heavy Atoms: 57 | QED Weighted: 0.12 | Np Likeness Score: -0.87 |
1. Mir FM, Atmuri NDP, Bourguet CB, Fores JR, Hou X, Chemtob S, Lubell WD.. (2019) Paired Utility of Aza-Amino Acyl Proline and Indolizidinone Amino Acid Residues for Peptide Mimicry: Conception of Prostaglandin F2α Receptor Allosteric Modulators That Delay Preterm Birth., 62 (9): [PMID:30932486] [10.1021/acs.jmedchem.9b00056] |
Source(1):